frrol
5 minutes ago
Re the OLE trial, people should compare its Secondary Outcome Measures (clinicaltrials.gov) to Missling's TLR, i.e. what was pre-specified (and very sensible, straightforward, and important) vs what was disclosed. Shades of his AUC and Odds Risk spinning.
I think Grimmer is presenting